Although the prevalence of all stages of diabetic retinopathy has been declining since 1980
in populations with improved diabetes control, the crude prevalence of visual impairment …

Diabetic retinopathy (DR) is a global health burden. Screening for sight-threatening DR
(STDR) is the first cost-effective step to decrease this burden. We analyzed the similarities …

IN BRIEF Diabetic retinopathy is one of the most prevalent but preventable blinding
diseases in the United States. This article reviews the pathophysiology of diabetic …

Diabetic retinopathy is a leading cause of vision impairment and blindness. We
systematically reviewed studies published from Jan 1, 1980, to Jan 7, 2018, assessed the …

1 MG Masding, A Adams, A Dawson, W Gatling, A countywide primary care annual audit
fails to demonstrate an improvement in diabetes care between 1996 and 2001, Practical …

Purpose Diabetic retinopathy (DR) is among the leading causes of visual loss in the working‐
age population. It is generally accepted that screening of DR is cost‐effective and can detect …

Background Diabetic retinopathy (DR) is a blinding yet treatable complication of diabetes.
DR screening is highly cost-effective at reducing blindness. Amidst the rapidly growing …

The aim of the English NHS Diabetic Eye Screening Programme is to reduce the risk of sight
loss amongst people with diabetes by the prompt identification and effective treatment if …

Despite advances in screening for and treatment of diabetes, diabetic retinopathy and
maculopathy are still major causes of visual loss around the world. Systematic screening …

Beginning with chapters summarizing the basics of diabetic retinopathy, this updated
volume outlines the need for screening, how to screen safely and correctly, and the normal …